The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.
The Department's UNIQ Oncology course invited students to explore the fascinating field of Oncology, to inspire those interested in pursuing a career in medical research.
Scientists from across Oncology and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences set off on the 15 June on a six-day road-trip.
Last week, budding scientists from the Beaconsfield 606 Air Cadets got a fascinating insight into the work being done to conceive a pharmaceutical or surgical \u201ccure\u201d for cancer.
How does the Department attract passionate and bright talent when it doesn\u2019t teach undergraduates? There are no \u2018home grown\u2019 students eager to become next year\u2019s doctoral students.
On Sat 23 March, four members of the Department of Oncology set out bars of chocolate on a table in the Market Square in Abingdon. Our aim? To introduce passers-by to some key concepts in radiotherapy.
Research by the DNA Damage & Disease research group has for the first time observed molecular fibres that may hold together sections of broken DNA in mitosis.
Researchers in Oxford have found that an individual\u2019s immune system \u2013 and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.
The Department of Oncology is pleased to announce that Professor Amato J Giaccia has been appointed as the new Director of the MRC Oxford Institute for Radiation Oncology (OIRO).
Researchers in the Department of Oncology have secured funding to characterise an insulin-like growth factor (IGF) signature for early detection and risk reduction of cancer.
Scientists from the Department of Oncology have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.
Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest \u00a310million in the National Consortium of Intelligent Medical Imaging (NCIMI), to be led from Oxford University as part of the Industrial Strategy Challenge Fund.
In July, the Department of Oncology was involved in the UNIQ Summer school, which is run as part of the University of Oxford\u2019s programme to increase diversity amongst students and is a committed supporter of making Oxford accessible to everyone.
![](\"https://www.oncology.ox.ac.uk/news/clinical-researchers-at-oxford-university-announce-new-collaboration-with-janssen-to-detect-blood-cancers-sooner/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n